Novo Holdings A/S’s CoLucid Pharmaceuticals, Inc. CLCD Stock Holding History

Novo Holdings A/S’s Portfolio CLCD Stock Details CLCD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-3,156,563	Closed	-$115M	–	25
2016 Q4	$115M	Hold	3,156,563	–	–	10.94%	3
2016 Q3	$120M	Buy	3,156,563 +100,000	+3%	+$1.48M	10.69%	4
2016 Q2	$25M	Hold	3,056,563	–	–	2.62%	8
2016 Q1	$19M	Hold	3,056,563	–	–	2.08%	6
2015 Q4	$25.6M	Hold	3,056,563	–	–	2.46%	5
2015 Q3	$11.8M	Hold	3,056,563	–	–	1.22%	13
2015 Q2	$27.2M	Buy	+3,056,563	New	+$26.2M	1.96%	11

Other funds holding CLCD

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Novo Holdings A/S's CLCD Position: Q1 2017 in Review

Novo Holdings A/S sold out of CoLucid Pharmaceuticals, Inc. (CLCD) in Q1 2017, closing a stake of 3,156,563 shares — an estimated $115M sold.

Novo Holdings A/S first reported a position in CLCD in Q2 2015 and held it in 7 quarters. The position peaked at $120M in Q3 2016. 1 fund tracked by Wall St. Rank holds CLCD as of Q1 2017.

Novo Holdings A/S reported no remaining CoLucid Pharmaceuticals, Inc. position as of Q1 2017 after selling out during the quarter.
Novo Holdings A/S sold 3,156,563 CoLucid Pharmaceuticals, Inc. shares in Q1 2017, an estimated $115M.
Novo Holdings A/S first reported a position in CoLucid Pharmaceuticals, Inc. in Q2 2015 and held it in 7 quarters.
Novo Holdings A/S's CoLucid Pharmaceuticals, Inc. position peaked at $120M in Q3 2016.
1 fund tracked by Wall St. Rank held CoLucid Pharmaceuticals, Inc. as of Q1 2017.

Based on Novo Holdings A/S's 13F filing for Q1 2017, filed 15 May 2017.